Rchr
J-GLOBAL ID:200901040894114975   Update date: Apr. 09, 2024

Yoshihara Satoshi

ヨシハラ サトシ | Yoshihara Satoshi
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://kaken.nii.ac.jp/ja/r/90461037
Research field  (1): Hematology and oncology
Research keywords  (5): CAR T-cell therapy ,  Multiple Myeloma ,  Hematopoietic Stem Cell Transplantation ,  Malignant lymphoma ,  Leukemia
Research theme for competitive and other funds  (3):
  • 2017 - 2020 An immunotherapy model for hematopoietic malignancies (multiple myeloma) using humanized mice
  • 2016 - 2019 Novel therapeutic strategy by intrabone marrow co-transplantation of cord blood and cord-derived mesenchymal stem cells
  • 2009 - 2011 Establishment of safety of HLA-haploidentical stem cell transplantation
Papers (120):
  • Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, et al. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. Annals of hematology. 2024
  • Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, et al. Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia. 2023
  • Takuto Takahashi, Masahiro Teramoto, Kana Matsumoto, Mutaz M Jaber, Hiroya Tamaki, Kazuhiro Ikegame, Satoshi Yoshihara, Katsuji Kaida. Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy. Clinical pharmacokinetics. 2023
  • Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Kaoru Kahata, Rie Yamazaki, Wataru Takeda, Yoshihiro Umezawa, Kentaro Fukushima, et al. Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan. British Journal of Haematology. 2023
  • 杉山 寛貴, 池本 純子, 辻本 真央, 山口 楓歌, 原田 由紀, 大塚 真哉, 小野本 仁美, 村田 理恵, 奥田 典子, 吉原 享子, et al. フローサイトメトリーを用いた末梢血中CAR-T細胞検出系の確立. 日本輸血細胞治療学会誌. 2023. 69. 2. 332-332
more...
MISC (92):
  • 城友泰, 城友泰, 平安山知子, 富澤大輔, 吉原哲, 吉原哲, 加畑馨, 藤原実名美, 奥山美樹, 柴徳生, et al. Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy. 臨床血液. 2023. 64. 5
  • 松田育雄, 吉原哲, 木原多佳子, 永井諒, 吉原享子, 今井康友, 石川恵理, 日笠聡, 金澤伸雄, 廣田誠一. A case of cutaneous infiltration of CD8-positive atypical T-cells with monoclonal integration of HTLV-1. 日本リンパ網内系学会会誌. 2022. 62
  • 吉原享子, 吉原哲, 吉原哲, 星山季子, 熊本友子, 佐守真実, 宇都宮惟人, 藤田佳之, 前田冬樹, 池本純子, et al. Prognosis after CAR T-cell therapy for relapse/refractory DLBCL. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
  • 小野本仁美, 池本純子, 辻本真央, 山口楓歌, 原田由紀, 杉山寛貴, 大塚真哉, 村田理恵, 奥田典子, 吉原享子, et al. Operation for CAR-T cell therapy using the existing facility. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
  • 吉原享子, 吉原享子, 吉原哲, 吉原哲, 小野本仁美, 池本純子, 藤田佳之, 山形冬樹, 佐守真実, 宇都宮惟人, et al. Kinetics of CAR T-cells in the peripheral blood after CD19-targeted CAR T-cell therapy. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
more...
Books (2):
  • EBM血液疾患の治療 2010-2011
    中外医学社 2009 ISBN:4498125525
  • 血液疾患治療の支持療法-最近の進歩
    医薬ジャーナル社 2006 ISBN:4753222233
Lectures and oral presentations  (7):
  • 造血幹細胞移植領域におけるHLA抗体の役割
    (第10回日本組織適合性学会近畿地方会 2012)
  • HLA半合致血縁者間移植 ~300例の臨床経験から~
    (第92回近畿血液学地方会 2009)
  • 造血幹細胞移植におけるHLA抗体の役割
    (第7回日本組織適合性学会近畿地方会 2009)
  • HLA 不適合血縁者間ミニ移植における早期キメリズム解析
    (第31回日本造血細胞移植学会総会 2009)
  • HLA不適合血縁者間移植
    (第90回近畿血液学地方会 2008)
more...
Education (2):
  • 2003 - 2007 Osaka University Graduate School of Medicine
  • 1993 - 1999 Osaka Univeresity Medical School
Work history (1):
  • 2009/04 - Hyogo College of Medicine Assistant professor
Awards (3):
  • 2011/10 - The Japanese Society of Hematology Young Investigator's Awards "The role of HLA antibodies in HLA-haploidentical SCT"
  • 2006/02 - BMT tandem meeting Travel grant award "Early diagnosis of extramedullary leukamia by WT1 monitoring"
  • 2006/02 - Japanese Society for Hematopoietic Cell Transplantation Research award "HLA-haploidentical SCT with reduced-intensity conditioning"
Association Membership(s) (6):
Japanese Society for Hematopoietic Cell Transplantation ,  Japanese Society of Hematology ,  THE JANPANESE SOCIETY OF INTERNAL MEDICINE ,  Japanese Association of Cancer Immunology ,  JAPANESE SOCIETY FOR IMMUNOLOGY (JSI) ,  THE JAPAN SOCIETY OF TRANSFUSION MEDIEINE AND CELL THERPY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page